Meningiomas and the polynesian population

ANZ Journal of Surgery

Volumn 75, Issue 8, 2005, Pages 705-709

  Olson, Sarah ^a,b   Law, Andrew ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b Monash Heart and Medical Centre   (Australia)

Author keywords

Caucasian; Insulin like growth factor 1; Meningioma; Polynesian

Indexed keywords

ARTICLE; CAUCASIAN; COMORBIDITY; ETHNOLOGY; FOLLOW UP; GROUPS BY AGE; HUMAN; MENINGIOMA; PACIFIC ISLANDER; SEX DIFFERENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEW ZEALAND; POLYNESIA; TREATMENT OUTCOME;

EID: 27844470723     PISSN: 14451433     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2005.03499.x     Document Type: Article

References (19)

1. Simmons D, Thompson CF, Volklander D. Polynesians: prone to obesity and type 2 diabetes but not hyperinsulinaemia. Diabet. Med. 2001; 18: 193-8.
2. Zankl H, Zand KD. Correlations between clinical and cytogenetical data in 180 human genetic meningiomas. Cancer Genet. Cytogenet. 1980; 1: 351-6.
3. Kahn J, Parsa NZ, Harada T. Detection of gains and losses in 18 meningiomas by comparative genomic hybridization. Cancer Genet Cytogenet. 1998; 103: 95-100.
4. Ikeda K, Saeki Y, Gonzalez-Agosti C, Ramesh V, Chiocca EA. Inhibition of NF2 negative and NF2 positive primary human meningioma cell proliferation by over expression of merlin due to vector mediated gene transfer. J. Neurosurg. 1999; 91: 85-92.
5. Kros J, De Greve K, Van Tilborg A et al. NF2 status of meningiomas is associated with tumour localisation and histology. J. Pathol. 2001; 194: 367-72.
6. Ozaki S, Nishizaki T, Ito H, Sasaki K. Comparative genomic hybridization analysis of genetic alterations associated with malignant progression of meningioma. J. Neurooncol. 1999; 41: 167-74.
7. Lamszus K, Kluwe L, Matschke J et al. Allelic losses at 1p, 9q, 10q, 14q and 22q in the progression of aggressive meningioma and undifferentiated meningeal sarcomas. Cancer Genet. Cytogenet. 1999; 110: 103-10.
8. Leone PE, Bello MJ, de Campos JM et al. NF2 mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas. Oncogene 1999; 18: 2231-9.
9. Peyrard M, Fransson I, Xie YG et al. Characterization of a new member of the human beta-adaptin gene family from chromosome 22ql2 a candidate meningioma gene 1994. Hum. Mol. Genet. 1994; 3: 1393-9.
10. Lekanne-Deprez RH, Reigman PH, Groen NA et al. Cloning and characterization of MN1, a gene from chromosome 22q11 which is disrupted by a balanced translocation in a meningioma. Oncogene 1995; 10: 1521-8.
11. Black PMcL. Meningiomas. Neurosurgery 1993; 32: 643-57.
12. Jacobs DH, McFarlane MJ, Holmes FF. Meningiomas and obesity reconsidered. Ann. Neurol. 1986; 20: 376.
13. Bellur SN, Chandra V, Andersons RJ. Association of meningioma with obesity. Ann. Neurol. 1983; 13: 346-7.
14. Glick RP, Gettleman R, Patel K, Lakshman R, Tsibris JC. Insulin and insulin-like growth factor I in brain tumour: binding and in vitro effects. Neurosurgery 1989; 24: 791-7.
15. Friend KE, Radinsky R, McCutcheon IE. Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist. J. Neurosurg. 1999; 91: 93-9.
16. McCutcheon IE, Flyvbjerg A, Hill H et al. Antitumour activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice. J. Neurosurg. 2001; 94: 487-92.
17. Lichtor R, Kurpakus MA, Gurney ME. Expression of insulin-like growth factors and their receptors in human meningiomas. J. Neurooncol. 1993; 17: 183-90.
18. Cannavo S, Curto L, Fazio R et al. Coexistance of growth hormone-secreting pituitary adenoma and intracranial meningioma: a case report and review of the literature. J. Endocrinol. Invest. 1993; 16: 703-8.
19. Bunick EM, Mills LC, Rose LI. Association of acromeglay and meningiomas. JAMA 1978; 240: 1267-8.